Granted Patent
B2
US 7,374,898 · App. 11/248,891 · Granted May 20, 2008
Peptide inhibitors against seprase
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention generally relates compositions and methods for the treatment of patients with melanoma and other malignant cancers. The compositions of the present invention are novel peptide sequences that inhibit seprase-mediated cell migration. Said sequences may also be used for diagnostics and library screening protocols.
Claims (2)
1. A composition comprising a polypeptide, wherein said polypeptide comprises the amino acid sequence set forth as in the group consisting of SEQ ID NO.: 1, and SEQ ID NO.: 2.
2. A cyclic peptide comprising the amino acid sequence of SEQ ID NO.: 1.
Assignments (2)
CONFIRMATORY LICENSE
Recorded Aug 15, 2010
From: STATE UNIVERSITY OF NEW YORK STONY BROOK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024837/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 2, 2006
From: CHEN, WEN-TIEN
To: RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE
Reel/Frame 017608/0643 →
Continuity (2)
Provisional Application
6061805300
· Oct 12, 2004